0001425738-13-000004.txt : 20130214
0001425738-13-000004.hdr.sgml : 20130214
20130214163956
ACCESSION NUMBER: 0001425738-13-000004
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20130214
DATE AS OF CHANGE: 20130214
EFFECTIVENESS DATE: 20130214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Redmile Group, LLC
CENTRAL INDEX KEY: 0001425738
IRS NUMBER: 208592298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12776
FILM NUMBER: 13614906
BUSINESS ADDRESS:
STREET 1: ONE LETTERMAN DRIVE
STREET 2: BUILDING D, SUITE D3-700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-489-9980
MAIL ADDRESS:
STREET 1: ONE LETTERMAN DRIVE
STREET 2: BUILDING D, SUITE D3-700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
13F-HR
1
red4q2012report.2.txt
4Q2012 13F-HR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: December 31, 2012
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Redmile Group LLC
Address: One Letterman Drive
Building D, Suite D3-700
San Francisco, CA 94129
13F File Number: 028-12776
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Jeremy Green
Title: Managing Member
Phone: 415-489-9980
Signature, Place, and Date of Signing:
/s/ Jeremy Green San Francisco, CA February 14, 2013
Report Type (Check only one.):
[ X] 13F HOLDINGS REPORT.
[ ] 13F NOTICE.
[ ] 13F COMBINATION REPORT.
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 40
Form 13F Information Table Value Total: $345,133 (thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional managers with respect to which this report is filed, other
than the manager filing this report.
NONE
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- --------
ACCURAY INC NOTE 3.750% 8/0 004397AB1 503 500000
ALIGN TECHNOLOGY INC COM 016255101 1610 580150
AMICUS THERAPEUTICS INC COM 03152W109 3006 1121700
ANTHERA PHARMACEUTICALS INC COM 03674U102 1111 1791800
ARIAD PHARMACEUTICALS INC COM 04033A100 21045 1097242
ARRAY BIOPHARMA INC COM 04269X105 16281 4376520
ARTHROCARE CORP COM 043136100 8993 260000
BIOSPECIFICS TECHNOLOGIES CO COM 090931106 4667 312152
CARDINAL HEALTH INC COM 14149Y108 18727 454750
CLOVIS ONCOLOGY INC COM 189464100 5649 353077
CONCEPTUS INC COM 206016107 11292 537472
CUTERA INC COM 232109108 3055 339457
CYCLACEL PHARMACEUTICALS INC COM NEW 23254L306 3791 672680
DYNAVAX TECHNOLOGIES CORP COM 268158102 15583 5448497
EXELIXIS INC COM 30161Q104 6278 1373654
EXELIXIS INC NOTE 4.250% 8/1 30161QAC8 4891 5000000
EXPRESS SCRIPTS HLDG CO COM 30219G108 16257 301050
GILEAD SCIENCES INC COM 375558103 21093 287170
GRIFOLS S A SP ADR REP B NVT 398438408 12559 484353
HCA HOLDINGS INC COM 40412C101 7995 265000
HEALTH MGMT ASSOC INC NEW CL A 421933102 192 20600
HEARTWARE INTL INC COM 422368100 19411 231226
IDENIX PHARMACEUTICALS INC COM 45166R204 146 30200
KYTHERA BIOPHARMACEUTICALS I COM 501570105 3344 110218
MEDIVATION INC COM 58501N101 10650 208172
MOMENTA PHARMACEUTICALS INC COM 60877T100 158 13400
NEUROCRINE BIOSCIENCES INC COM 64125C109 6045 808100
ONYX PHARMACEUTICALS INC COM 683399109 33316 441101
OPTIMER PHARMACEUTICALS INC COM 68401H104 4697 519000
OREXIGEN THERAPEUTICS INC COM 686164104 6531 1239240
PUMA BIOTECHNOLOGY INC COM 74587V107 8148 434570
SALIX PHARMACEUTICALS INC COM 795435106 18244 450700
SEQUENOM INC COM NEW 817337405 12605 2670518
STRYKER CORP COM 863667101 21785 397400
TESARO INC COM 881569107 1646 97109
TRANS1 INC COM 89385X105 2063 831963
TRIUS THERAPEUTICS INC COM 89685K100 3179 665067
UNITEDHEALTH GROUP INC COM 91324P102 271 5000
UNIVERSAL HLTH SVCS INC CL B 913903100 5560 115000
VANGUARD HEALTH SYS INC COM 922036207 2756 225000